SonoSite’s Q4 net plunges on flat sales

SonoSite Inc. (NSDQ:SONO) posted fourth-quarter sales of $69.7 million for the three months ended Dec. 31, 2009, flat compared with $70.1 million during the same period in 2008. Net income fell 63.4 percent to $2.2 million, compared with $6 million during Q4 2008:

Press Release

SonoSite Achieves 9% Operating Margins in Spite of a 10% Revenue
Decline in FY 2009

Q4 2009 Operating Income Grows 117% as Operating Margins Hit 15.4%
Excluding Non-recurring Items

Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern

BOTHELL, Wash.–(BUSINESS WIRE)–SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in
hand-carried ultrasound for the point-of-care, today reported financial
results for the fourth quarter and year ended December 31, 2009.


Revenues in the fourth quarter of 2009 were $69.7 million, a decrease of
1% compared to the fourth quarter of 2008. Full year of 2009 revenues
were $227.4 million, down 7% versus full year of 2008.

Revenues for the partial year acquisition of CardioDynamics were $4.2
million for the fourth quarter and $7.1 million for the full year of

Excluding partial year revenues from CDIC, SonoSite fourth quarter
revenues were $65.5 million, down 7% versus the fourth quarter of 2008.
Full year revenues excluding CDIC were $220.3 million, a decrease of 10%
compared to 2008.

Changes in foreign currency rates increased worldwide revenues by 4% in
the fourth quarter and decreased revenues by 2% for the full year.


Fourth Quarter Results

Fourth quarter operating income was $6.8 million, an increase of 46%
compared to the fourth quarter of 2008. Operating income for the fourth
quarter 2009 included charges from CDIC of $3.3 million, related to
operating results as well as acquisition and integration.

Excluding CDIC, operating income in the fourth quarter of 2009 was $10.1
million, an increase of 117% compared to the fourth quarter of 2008.
Operating margins reached 15.4% for the quarter.

Full Year Results

For the full year of 2009, operating income was $13.7 million, including
charges from CDIC of $6.9 million; a decrease of 39% compared to the
full year of 2008.

Excluding CDIC, full year of 2009 operating income was $20.6 million,
down 8% versus the full year of 2008 on a $24 million or 10% revenue
decline versus full year 2008.

Cash Flow

Operating cash flow was $15.3 million for the quarter and $24.4 million
for the full year of 2009, as compared to $11.2 million and $29.2
million for the comparable periods of 2008. Operating cash flow for the
full year of 2009 reflects the $21 million received to settle a patent
dispute in the fourth quarter.

Net income

For the fourth quarter of 2009, the Company recorded net income of $2.2
million or $0.12 per share, compared to $6.0 million or $0.34 per share
in 2008. For the full year of 2009, net income was $3.2 million or $0.18
per share compared to $11.2 million or $0.64 per share for the full year
of 2008. Excluding non-recurring items such as bond gains, acquisition
expenses, and patent royalty revenue, net income would have been $0.36
per share for the full year of 2009 or essentially even with 2008.


“In a very tough year we simply got stronger as a company, improving our
operating model and tightening our capital allocation process,” said
Kevin M. Goodwin, SonoSite President and CEO. “We successfully
integrated CardioDynamics which included significant changes to their
sales force during the fourth quarter, while successfully closing out
our litigation matters and achieving 9% operating margins, a level
similar to 2008, despite core revenues falling by $24 million or 10%.”

“With a difficult year behind us we are stronger and more focused on
growth initiatives for 2010 and beyond. We have leaned out our ‘SG&A
structure’ and are deploying our strategy across four key vertical
markets,” said Mr. Goodwin.

“We have also initiated market development in cardiovascular disease
management markets enabling us to expand our role in the cardiovascular
health marketplace.”

“Additionally, we are at work on revising our capital structure with the
recently announced “Dutch Auction” tender offer to repurchase $100
million of our shares. Following a two year evaluation of investment
alternatives, it became clear to us that investing in our own stock was
our best choice,” Mr. Goodwin further commented.

As of December 31, 2009, the company held $257.7 million in cash and
investments and had outstanding senior convertible notes of $114.7
million for net liquidity of $143.0 million.


The company provided the following guidance:

  • Revenue growth of up to 10%
  • Level gross margin
  • Operating margin of 11 – 13%

RSS From Medical Design & Outsourcing

  • Procyrion CEO discusses its life-changing pump designed to heal the heart
    Ben Hertzog is the CEO of Procyrion, a Houston-based company that is developing Aortix, a custom designed pump built around a powerful micro-motor mounted on a set of expandable struts. Aortix is designed to rest and heal the heart by reducing afterload and improving blood flow to vital organs. Unlike other circulatory assist devices that […]
  • U.S. Based Qure Medical Acquires UK-Headquartered Silicone Altimex
    Qure Medical, with corporate headquarters in Twinsburg, Ohio, has acquired UK-headquartered Silicone Altimex, announced Randy Ross, President and CEO of Qure Medical. Financial terms of the agreement were not disclosed. Qure Medical provides integrated elastomer solutions to medical device manufacturers. Silicone Altimex is one of Europe’s leading independent manufacturers of cleanroom-produced silicone tubing components and […]
  • Coatings2Go is issued U.S. Patent for hydrophilic coating
    Coatings2Go, a medical device coating supplier, recently announced its receipt of a patent as it relates to hydrophilic coatings. The U.S. Patent Office has issued to Coatings2Go a patent with a grant date of July 14, 2015: U.S. Patent Number 9,080,061, “Coating Resins And Coatings With Multiple Crosslink Functionalities.” “This new patent is the third […]
  • Herrmann Ultrasonics, Inc. announces its 25 Year Anniversary
    In 1990, Thomas Herrmann, the son of Walter Herrmann, who founded Herrmann Ultraschalltechnik GmbH in 1961, established Herrmann Ultrasonics Inc. in the Chicago area. Hermann Ultrasonics, Inc. is proud to recognize a milestone year in observance of their 25th anniversary. Herrmann Ultrasonics has been focused on providing ultrasonic welding technology for various markets such as […]
  • Consumer Health Applications receive the most attention today, but the future is elsewhere
    Wearables for health fall into a wide range of technologies, functions, use cases and over-arching regulatory frameworks that developers and prospective entrants have to understand in order to effectively compete. Using an underlying taxonomy for human health, we establish a health-focused wearables taxonomy around three major categories—applications, use cases, and form factors—the three areas critical […]
  • Paralyzed men move legs with new non-invasive spinal cord stimulation
    Five men with complete motor paralysis were able to voluntarily generate step-like movements thanks to a new strategy that non-invasively delivers electrical stimulation to their spinal cords, according to a new study funded in part by the National Institutes of Health. The strategy, called transcutaneous stimulation, delivers electrical current to the spinal cord by way […]
  • SCHURTER’s new power entry module offers IP 54 protection with V-Lock cord sets
    SCHURTER is pleased to announce, that its power entry module, series 5707, now offers IP 54 protection with V-Lock cord sets at the power input, in addition to IP 65 protection to the equipment. The sealed module is ideal for use in medical equipment exposed to leaks, drips and spills, as well as equipment subject […]
  • GlobTek presents its latest level VI AC/DC adapter and connverter
    T-43086-WWVV-X.X-Q Model is an addition to GlobTek’s Level VI compliant GT-43086 family and represents GlobTek’s 6 Watt wall plug-in series of AC/DC adapters (power supplies and chargers) with International Interchangeable blades. GlobTek’s changeable input blade system with individual field replaceable input plugs, including: North America and Japan NEMA 1-15P, Australian, UK BS 1363, European CEE […]
  • Sanmina’s familiarity with FDA gets skin treatment product to market fast
    The medical market for cosmetic devices is booming. However, quickly launching new products to meet demand is becoming more challenging because device manufactures face increased regulatory scrutiny. To help meet regulatory requirements, aesthetic and other medical-device OEMs are partnering with electronics manufacturing services (EMS) companies that also offer expertise with the FDA filings necessary to […]
  • Fluid connectors and quick disconnects for IVD equipment from CPC
    Colder Products Company (CPC) offers thousands of tubing connectors, quick disconnects and fittings for smart fluid handling in IVD and analytical equipment. Non-spill connectors speed testing throughput by eliminating drips, preventing air inclusion and increasing operator safety. Panel mount connectors can be added to existing equipment or bottle caps to provide secure, leak-free connections. Puncture […]
  • 310 Watt desktop medical power supply meets efficiency level VI requirements
    Power Partners releases a new 310 Watt medical grade desktop power supply from their PEAMD Series of AC and DC adapters. The 310 Watt unit is packed for ideal performance inside a compact case measuring 7.8 x 4 x 2 in. with a weight of only 3 lbs. The PEAMD310 Series is approved to the latest […]

Leave a Reply